Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Autolus Therapeutics plc publishes a filing, an earnings call transcript or a press release.

Get AUTL alerts

About Christian Aiton

Christian Aiton is recorded as CEO at Autolus Therapeutics plc (AUTL). Christian Aiton has spoken on 2 earnings calls and 6 other investor events across 1 company, most recently for Autolus Therapeutics plc on June 30, 2026. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Michael W. Bonney (Chairman and Board Member), Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer) and 4 others.

Christian Aiton on recent calls

“Well, thanks, Emily, for the invitation. Pleasure to be here. The focus that we had when we started the company was to come up with a CAR T-cell therapy that allows you to sort of mimic the physiological way and how T-cells actually do attack and recognize cells and take them out.”
CEO, H.C. Wainwright 4th Annual Cell Therapy Virtual Conference ·
“Well, thanks, Emily, for the invitation. Pleasure to be here. The focus that we had when we started the company was to come up with a CAR T-cell therapy that allows you to sort of mimic the physiological way and how T-cells actually do attack and recognize cells and take them out.”
CEO, H.C. WAINWRIGHT 4TH ANNUAL CELL THERAPY VIRTUAL CONFERENCE ·
“Now, before I start growing you with more detailed questions, how about you give the audience some highlights on, you know, how the business is going I know you have some interesting updates at the most recent earning just give us some color on that yeah happy to do that thanks for having us thanks for for taking the…”
CEO, Jefferies Global Healthcare Conference ·
“Thanks for having us and really appreciate you're all here and I hope you found some food on the way so that we're kind of making it through the presentation. Obviously, also the usual disclaimers.”
CEO, WILLIAM BLAIR’S 46TH ANNUAL GROWTH STOCK CONFERENCE ·
“Moving to slide number four, we had a very good first quarter, and we see a nice traction building both in the U.S. And obviously, in our early launch in the UK as well.”
CEO, Autolus Therapeutics plc Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Autolus Therapeutics plc

Recent activity